Gland Pharma consolidated net profit declines 15.74% in the September 2024 quarter
Sales rise 2.36% to Rs 1405.83 crore
Net profit of Gland Pharma declined 15.74% to Rs 163.53 crore in the quarter ended September 2024 as against Rs 194.08 crore during the previous quarter ended September 2023. Sales rose 2.36% to Rs 1405.83 crore in the quarter ended September 2024 as against Rs 1373.42 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales1405.831373.42 2 OPM %21.1323.60 -PBDT350.60371.19 -6 PBT256.78289.89 -11 NP163.53194.08 -16Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 05 2024 | 7:30 AM IST